Patent Issued for Pharmaceutical compositions comprising (s)-4-(4-(4- (((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrtle and methods of using the (USPTO 11779580).
In: Hematology Week, 2023-10-31, S. 807-807
serialPeriodical
Zugriff:
"Current multiple myeloma therapy may involve one or more of surgery, stem cell transplantation, chemotherapy, immune therapy, and/or radiation treatment to eradicate multiple myeloma cells in a patient. Apoptosis, B-Lymphocytes, Biopharmaceutical Companies, Biotechnology Companies, Blood, Blood Cells, Blood Protein Disorders, Bone Marrow, Bone Research, Business, Cancer, Celgene Corporation, Cellular Physiology, Cytometry, Dosage Forms, Drugs and Therapies, Genetics, Health and Medicine, Healthcare Biotechnology Companies, Hematologic Diseases and Conditions, Hematology, Hemic and Immune Systems, Hemic and Lymphatic Diseases and Conditions, Hemorrhagic Disorders, Hemostatic Disorders, Immune System, Immunology, Immunoproliferative Disorders, Leukocytes, Lymphoproliferative Disorders, Multiple Myeloma, Myeloma, Oncology, Paraproteinemias, Pharmaceuticals, Plasma, Plasma Cells, Residual Neoplasms, Risk and Prevention, Therapy, Vascular Diseases and Conditions BACKGROUND "Multiple myeloma (MM) is a cancer of plasma cells in the bone marrow. [Extracted from the article]
Copyright of Hematology Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Patent Issued for Pharmaceutical compositions comprising (s)-4-(4-(4- (((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrtle and methods of using the (USPTO 11779580).
|
---|---|
Zeitschrift: | Hematology Week, 2023-10-31, S. 807-807 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1543-673X (print) |
Schlagwort: |
|
Sonstiges: |
|